The way the healthcare industry thinks about interoperability doesn’t capture the whole story.  Interoperability is often described as ensuring that the right participants can access the right patient information at

Merck has FDA approval for a new combination drug for HIV, giving patients a new treatment option and an alternative to a blockbuster Gilead Sciences pill that comes with tolerability

The U.S. Department of Justice is seeing numerous trends of fraud in the Affordable Care Act Marketplace targeting vulnerable populations. At the Medicarians Conference in Las Vegas on Monday, an

Over the past decade or so, I’ve watched on with fascination as consumer wearables have evolved from simple fitness accessories into increasingly sophisticated health tools. Smart rings, watches, patches and

One big news story from the world of Medicare Advantage recently has been the number of plans that are in retrenchment mode. For instance, UnitedHealthcare reportedly exited 109 counties for

Tortugas Neuroscience launched from stealth Tuesday with $106 million to support a pipeline of four in-licensed drugs in clinical development for a range of central nervous system indications. The programs

For years, payment integrity was built around simple assumptions: errors can be fixed after payment. In today’s environment of rising medical costs and accelerating claims volume, that approach isn’t sustainable.

At the annual Medicarians conference in Las Vegas on Monday, an analyst on Medicare Advantage policy research sounded the alarm about how there’s a fundamental shift in attitude towards MA

Eli Lilly is expanding its reach in genetic medicines with a multi-billion dollar deal to acquire Kelonia Therapeutics, a startup whose most advanced drug candidate is a cell therapy in

Workplace violence is a persistent and worsening problem in healthcare. According to the Bureau of Labor Statistics, healthcare workers are five times more likely to experience workplace violence than those